EGLN1 and hyperinsulinemic hypoglycemia, familial, 4: Polycytemia without an identifiable etiology, evaluation of erythrocyte 2,3-DPG levels, bisphosphoglycerate mutase deficiency, and oxygen-sensing pathway gene mutations (EpoR, VHL, PHD2) were not possible due to technical limitations.